In glioblastoma and ovarian cancer, KLF9 was shown to repress the expression of the Notch 1 gene, thereby resulting in reversion away from the stem cell phenotype due to less active Notch signaling [154,157]. The gene discussed is KLF9; the disease is glioblastoma.